COLTENE Holding Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

COLTENE Holding wird ein jährliches Gewinn- und Umsatzwachstum von 22.3% bzw. 2.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 22.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 21.5% betragen.

Wichtige Informationen

22.3%

Wachstumsrate der Gewinne

22.9%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum15.0%
Wachstumsrate der Einnahmen2.8%
Zukünftige Eigenkapitalrendite21.5%
Analystenabdeckung

Low

Zuletzt aktualisiert15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Update: COLTENE Holding AG (VTX:CLTN) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Mar 13
Earnings Update: COLTENE Holding AG (VTX:CLTN) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Recent updates

Earnings Update: COLTENE Holding AG (VTX:CLTN) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

Mar 13
Earnings Update: COLTENE Holding AG (VTX:CLTN) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts

COLTENE Holding AG's (VTX:CLTN) Business And Shares Still Trailing The Market

Jan 21
COLTENE Holding AG's (VTX:CLTN) Business And Shares Still Trailing The Market

At CHF83.10, Is COLTENE Holding AG (VTX:CLTN) Worth Looking At Closely?

Jun 15
At CHF83.10, Is COLTENE Holding AG (VTX:CLTN) Worth Looking At Closely?

COLTENE Holding AG (VTX:CLTN) Analysts Are Pretty Bullish On The Stock After Recent Results

Mar 08
COLTENE Holding AG (VTX:CLTN) Analysts Are Pretty Bullish On The Stock After Recent Results

Should You Investigate COLTENE Holding AG (VTX:CLTN) At CHF88.90?

Mar 08
Should You Investigate COLTENE Holding AG (VTX:CLTN) At CHF88.90?

Is COLTENE Holding (VTX:CLTN) Using Too Much Debt?

Nov 09
Is COLTENE Holding (VTX:CLTN) Using Too Much Debt?

Is It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?

Sep 29
Is It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?

COLTENE Holding (VTX:CLTN) Has A Pretty Healthy Balance Sheet

May 29
COLTENE Holding (VTX:CLTN) Has A Pretty Healthy Balance Sheet

How Does COLTENE Holding AG (VTX:CLTN) Fare As A Dividend Stock?

Apr 01
How Does COLTENE Holding AG (VTX:CLTN) Fare As A Dividend Stock?

Is Now The Time To Look At Buying COLTENE Holding AG (VTX:CLTN)?

Mar 14
Is Now The Time To Look At Buying COLTENE Holding AG (VTX:CLTN)?

Shareholders Of COLTENE Holding (VTX:CLTN) Must Be Happy With Their 84% Return

Feb 24
Shareholders Of COLTENE Holding (VTX:CLTN) Must Be Happy With Their 84% Return

Is COLTENE Holding AG's (VTX:CLTN) ROE Of 16% Impressive?

Jan 28
Is COLTENE Holding AG's (VTX:CLTN) ROE Of 16% Impressive?

Is COLTENE Holding AG's (VTX:CLTN) Shareholder Ownership Skewed Towards Insiders?

Jan 11
Is COLTENE Holding AG's (VTX:CLTN) Shareholder Ownership Skewed Towards Insiders?

Does COLTENE Holding (VTX:CLTN) Have A Healthy Balance Sheet?

Dec 17
Does COLTENE Holding (VTX:CLTN) Have A Healthy Balance Sheet?

Is It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?

Dec 03
Is It Time To Consider Buying COLTENE Holding AG (VTX:CLTN)?

COLTENE Holding's (VTX:CLTN) Shareholders Are Down 25% On Their Shares

Nov 20
COLTENE Holding's (VTX:CLTN) Shareholders Are Down 25% On Their Shares

Shorn Like A Sheep: Analysts Just Shaved Their COLTENE Holding AG (VTX:CLTN) Forecasts Dramatically

Jun 22
Shorn Like A Sheep: Analysts Just Shaved Their COLTENE Holding AG (VTX:CLTN) Forecasts Dramatically

Gewinn- und Umsatzwachstumsprognosen

SWX:CLTN - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CHF Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20262642519292
12/31/20252562318282
12/31/20242512023332
6/30/2024239121422N/A
3/31/2024241121624N/A
12/31/2023243121726N/A
9/30/2023253182129N/A
6/30/2023264242433N/A
3/31/2023265252028N/A
12/31/2022267261523N/A
9/30/2022269261827N/A
6/30/2022271262130N/A
3/31/2022275292231N/A
12/31/2021279322333N/A
9/30/2021284292736N/A
6/30/2021288263140N/A
3/31/2021268172837N/A
12/31/202024882535N/A
9/30/2020245101929N/A
6/30/2020242121324N/A
3/31/2020258161224N/A
12/31/2019274201024N/A
9/30/2019264191024N/A
6/30/201925419925N/A
3/31/2019229181025N/A
12/31/2018204171225N/A
9/30/2018190181323N/A
6/30/2018176191522N/A
3/31/201817219N/A22N/A
12/31/201716819N/A22N/A
9/30/201716618N/A24N/A
6/30/201716316N/A26N/A
3/31/201716217N/A24N/A
12/31/201616117N/A23N/A
9/30/201615917N/A21N/A
6/30/201615717N/A19N/A
3/31/201615615N/A18N/A
12/31/201515513N/A18N/A
9/30/201515714N/A18N/A
6/30/201516014N/A19N/A
3/31/201516115N/A19N/A
12/31/201416216N/A20N/A
9/30/201416215N/A24N/A
6/30/201416114N/A27N/A
3/31/201416113N/A25N/A
12/31/201316013N/A23N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CLTNDas prognostizierte Gewinnwachstum (22.3% pro Jahr) liegt über der Sparquote (0.3%).

Ertrag vs. Markt: CLTNDie Erträge des Unternehmens (22.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swiss (11.4% pro Jahr).

Hohe Wachstumserträge: CLTNEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: CLTNDie Einnahmen des Unternehmens (2.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Swiss (4.2% pro Jahr).

Hohe Wachstumseinnahmen: CLTNDie Einnahmen des Unternehmens (2.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CLTNDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (21.5%)


Wachstumsunternehmen entdecken